Table 2 Frequency of NIDIAG priority infections and of other clinical diagnoses in 1922 patients evaluated for persistent fever, per study country

 Enteric fever

11 (1.6)

9 (3.0)

8 (1.4)^a

6 (1.6)

34 (1.8)

  Salmonella Typhi

9

9

5

–

23

  Salmonella Paratyphi A

2

–

3

6

11

 Leptospirosis

13 (1.8)

10 (3.3)

30 (5.2)

24 (6.3)

77 (4.0)

  Confirmed

1

5

13

12

31

  Probable

12

5

17

12

46

 Rickettsiosis

1 (0.1)

5 (1.7)

28 (4.7)

10 (2.6)

44 (2.3)

  Rickettsia typhi^b

–

5

5

8

18

  Orientia tsutsugamushi^c

–

–

11

2

13

  Rickettsia spp.^d

1

–

12

–

13

 Relapsing fever

7 (1.0)

–

4 (0.7)

1 (0.3)

12 (0.6)

 Brucellosis

28 (4.2)

–

–

–

28 (1.5)

 Melioidosis

–

–

–

16 (4.2)

16 (0.8)

 Visceral leishmaniasis

65 (9.7)

–

56 (9.7)

–

119 (6.2)

 Human African trypanosomiasis

–

2 (0.7)

–

–

2 (0.1)

 Amebic liver abscess

–

–

1 (0.2)

11 (2.9)

12 (0.6)

 Malaria

55 (8.2)

96 (32.0)

–

4 (1.1)

154 (8.0)

 Tuberculosis^e

8 (1.2)

18 (6.0)

27 (4.7)

76 (20.1)

129 (6.7)

 New HIV diagnosis/opportunistic infection (other than tuberculosis)

4 (0.6)

4 (1.3)

4 (0.7)

2 (0.5)

14 (0.7)

 Other (suspected) systemic bacterial infections

2 (0.3)

11 (3.7)

2 (0.3)

29 (7.7)

44 (2.3)

 Suspected focal bacterial infections

101 (5.3)

47 (15.7)

55 (9.5)

161 (42.6)

364 (18.9)

  Pneumonia

23 (3.4)

22 (7.3)

20 (3.5)

83 (22.0)

148 (7.7)

  Abdominal/intestinal infection

12 (1.8)

7 (2.3)

4 (0.7)

26 (6.9)

49 (2.5)

  Genitourinary infection

63 (9.4)

13 (4.3)

31 (5.4)

26 (6.9)

133 (6.5)

  Skin and soft tissue infection

3 (0.4)

5 (1.7)

–

26 (6.9)

34 (1.4)

 Suspected viral infection (respiratory/other)

54 (8.1)

29 (9.7)

76 (13.2)

5 (1.3)

164 (8.5)

 Other infections (parasitic, fungal)

2 (0.3)

2 (0.7)

–

6 (1.6)

10 (0.5)

 Non-infectious etiologies

9 (1.3)

1 (0.3)

11 (1.9)

17 (4.5)

38 (2.0)

 Unknown/unspecified cause

333 (49.9)

80 (26.7)

278 (48.2)

54 (14.3)

745 (38.8)